
Auteur M. HERMANNS-CLAUSEN
|
Documents disponibles écrits par cet auteur (4)

M. HERMANNS-CLAUSEN ; S. KNEISEL ; M. HUTTER ; B. SZABO ; V. AUWÄRTER | 2013
Dans Drug Testing and Analysis (Vol.5, n°9-10, September-October 2013) Article : PériodiqueRecently, synthetic cannabinoids appeared on the drug market, mostly as undeclared additives in 'herbal mixtures' named for example 'Spice', 'Lava Red' or 'Jamaican Gold'. The use of synthetic cannabinoids is driven by several factors. After the[...]
M. HERMANNS-CLAUSEN ; S. KNEISEL ; B. SZABO ; V. AUWÄRTER | 2013
Dans Addiction (Vol.108, n°3, March 2013) Article : PériodiqueAims: Recently, several synthetic cannabinoids were identified in herbal mixtures consumed as recreational drugs alternative to cannabis products. The aim was to characterize the acute toxicity of synthetic cannabinoids as experienced by emergen[...]
A. KADER ; M. HERMANNS-CLAUSEN ; A. VAN RIEL ; K. FABER ; L. HONDEBRINK | 2025
Dans Clinical Toxicology (Vol.63, n°1, January 2025) Article : PériodiqueINTRODUCTION: Common recreational drugs and new psychoactive substances pose challenges to public health. This study investigated the feasibility of merging cases of recreational drug poisoning reported to European poison centres. METHODS: Four[...]
M. J. SOMMER ; S. HALTER ; V. ANGERER ; V. AUWARTER ; F. EYER ; G. LIEBETRAU ; M. EBBECKE ; M. HERMANNS-CLAUSEN | 2022
Dans Clinical Toxicology (Vol.60, n°10, October 2022) Article : PériodiqueContext: New psychoactive substances (NPS) have become an ongoing threat to public health. To prevent the emergence and spread of NPS, a new German law, the 'NpSG' took effect in November 2016. This study presents an overview of analytically con[...]